For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.
1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.
Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box
Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.
Price and Minumum Quantity
Price FOB in USD: NegotiableMinimum Order Qty: 10000
Production Capacity: 1000000Packaging: 25 Persons/box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: Easysweet
HS Code: 3822009020
Standards: Ce
Competitive Advantages
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Other Details
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Name: Novel Coronavirus (SARS-Cov-2) Antigen Rapid test Cassette (saliva).
Quality: Applicable Standarts: EN ISO 13485:2016; EN ISO 15223-1:2016; EN ISO 14971:2012; EN ISO 13612:2002; EN ISO 17511:2003; EN ISO 18113-1:2011; EN ISO 23640:2015. Tests meets the provisions of the Directive 98/79/EC of the European Parliament and of the Council on In-Vitro Diagnostic Medical Devices
Origin: China, manufacturer HANGZHOU REALY TECH CO, LTD.
Quantity: 100 000 Cassettes per week. 1 pallet Cassettes;
Packing: 5 test kits/ inner box, 500 tests/carton, Gross weight per carton: 9.2 KGS;
Delivery terms: FCA Vilnius, Lithuania (EU) (Incoterms 2010);
The price includes customs duties and transport, VAT 0%;
Product Description - Covid-19 SARS-CoV-2 Saliva Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 Saliva antigen (Ag) in human oropharyngeal (OP), nasal (NS), nasopharygeal (NP) swab, saliva or gargled water specimens from individuals who meet Covid-19 clinical criteria.
OTG Europe Cash & Carry stocks of varying quantities of Singclean COVID-19 Antigen Rapid Test.
Various IFUs available.
Quantities available and pricing may vary by the hour.
Purchases from 1000 tests to hundreds of thousands.
Larger orders obtain best pricing, lower orders can be catered for with prices generally ranging from Euro 1.50~2.50.
We are the authorized first vendor of ADTech!
KFDA CE approved,
FDA Pending
Price : Negotiable
Pre-Clinical Test Report
Accuracy
- In total samples 93.3% (14/15) - In positive samples 91.7% (11/12)
1. Pre-Clinical Test summary
1) Pre-clinical test is fulfilled by Domestic large clinical laboratory with ADTech COVID-19 IgM/IgG RAPID KIT
2) Tests are made by total 15 samples with 12 positive and 3 negative samples
3) Clinical Laboratory tested the sample with Immunofluorescence Analysis
2. Pre-clinical test result
1) Samples were tested by ADTech COVID-19 IgM/IgG RAPID KIT
2) Test result by ADTechs RAPID KIT
- 4 negatives and 11 positives results in 15 samples
3) Comparison between Immunofluorescence analysis and ADTechs RAPID KIT
- 14 test results are same(including negative and positive results) - 1 samples test result are different(Positive Negative by ADTech
Name: Novel Coronavirus (SARS-Cov-2) Antigen Rapid test Cassette (swab).
Quality: Applicable Standarts: EN ISO 13485:2016; EN ISO 15223-1:2016; EN ISO 14971:2012; EN ISO 13612:2002; EN ISO 17511:2003; EN ISO 18113-1:2011; EN ISO 18113-1:2011; EN ISO 23640:2015. Tests meets the provisions of the Directive 98/79/EC of the European Parliament and of the Council on In-Vitro Diagnostic Medical Devices
Origin: China, manufacturer HANGZHOU REALY TECH CO, LTD.
Quantity: 100 000 Cassettes per week.;
Packing: 5 test kits/ inner box, 500 tests/carton, Gross weight per carton: 9.2 KGS;
Delivery terms: FCA Vilnius, Lithuania (EU) (Incoterms 2010)
The price includes customs duties and transport, VAT 0%;
Offering Alltest Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania. Good price from authorised Alltest distributor.
We can supply millions of Rapid Test Kit for Covid 19 using Saliva or Swab immediately. Interested serious clients may contact us directly on our given email or WhatsApp.
Access Bio Care Start Covid-19 Rapid Antigen Test Kit
Product Details:
Number of Reactions(Preps) per Kit : 1
Brand : Access Bio
Test Method : Antigen Test
Result Time (Rapid Kits) : 10 min
Sample Type ; Nasal Swab
Packaging Size : 20 Test Kits/Box
Packaging Type : Box
The CareStart COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between
